- Poster presentation
- Open Access
7T versus 3T phosphorous magnetic resonance spectroscopy in patients with dilated cardiomyopathy
© Stoll et al; licensee BioMed Central Ltd. 2015
- Published: 3 February 2015
- Field Strength
- Magnetic Resonance Spectroscopy
- Dilate Cardiomyopathy
- British Heart Foundation
- Myocardial Energetic
Phosphorous magnetic resonance spectroscopy (31P-MRS) allows insight into cardiac energetics in vivo, but it is a technique with an intrinsically low signal to noise ratio (SNR). The 2.4x increased SNR, that is predicted by theory at 7T compared to 3T, should allow detection of smaller changes in metabolite concentrations or measurement of changes in smaller patient groups, which will further our understanding of cardiac energetics. This study represents the first cardiac 31P-MRS patient data acquired at a 7 Tesla field strength.
10 dilated cardiomyopathy patients were enrolled. All underwent 31P-MRS at 3T and 7T field strengths. There were 4 females and 6 males; mean age 57 years (range 36-72). All patients were NYHA Class I (40%) or Class II (60%), and the mean LV ejection fraction was 38%.
As expected, the change in field strength from 3T to 7T resulted in an increased mean SNR from 7 ± 1.4 to 18 ± 9.3 for PCr (p 0.005 paired t-test) and for γATP an increase from 4.1 ± 1.1 to 12.0 ± 3.4 (p 0.0002).The ATP line width increased from 8.9 ±1.7Hz at 3T to 34.1 ± 14.5 at 7T (p 0.0008) a 281% increase, compared to a previously reported increase of 131%. This suggests that more careful B0 shimming may be required in patients than in healthy volunteers.
The Cramer-Ráo Lower Bounds (CRLB) are shown in figure 1b. The mean PCr/ATP CRLB was 40 ± 9% at 3T compared to 20 ± 7% at 7T (p 0.002). The CRLB gives a lower bound to the accuracy of the fitted parameters. Hence, this decrease represents a desirable increased precision in metabolite quantitation at 7T compared to 3T.
Compared to a 2.8x SNR increase from 3T to 7T previously reported in normal volunteers, we observed a 2.6x increase in this population of patients. The PCr/ATP ratio is not significantly different between the field strengths, showing there is no significant new bias at 7T. 7T 31 P-MRS has been previously shown to be feasible in healthy volunteers and now in patients, which in future should allow more accurate quantification and understanding of myocardial energetics.
Dr Victoria Stoll is funded by the British Heart Foundation FS/12/14/29354. The research was supported by a Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society [Grant Number 098436/Z/12/Z] and by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at The Oxford University Hospitals Trust at the University of Oxford.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.